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CARDIAC TAMPONADE: CLINXCAL FEATURES AND MANAGEMENT _-- 
BY SUBXIPHOID PERICARDIOTOW 
Paul T. Carnob& Thomas C. Wall, Christopher M. O’Connor, Peter Van 
Trigt, Richard T. Kenney, Khahd H. Sheikh, Joseph A. Kisslo, G. Ralph 
Corey. Duke University Medical Center, Durham, N.C., USA. 
To determine the clinical features, course and outcome of patients tpts) 
with cardiac tamponade (CT), we prospectively studied 57 consecutive pts 
with new, large pericardial effusions (PE). CT (defined as a PE associated 
with venous hypertension and either a paradox of > 10 mmHg, a blood 
pressure of c 90/60 mmHg or cardiac catheterization-documented 
equalization of pressure) was present in 25 (44%) of these 57 pts and all 
underwent subxiphoid pericardial biopsy and drainage. The diagnoses 
consisted of collagen-vascular disease (CVD) (SLE or rheumatoid 
arthritis) in 6 pts (24%); malignancy in 6 pts (24%); uremia in 4 pts (16%); 
viral in 2 pts (8%); and radiation, tuberculosis, sympathetic, post- 
myocardial infarction and drug-induced, each in 1 pt (4%) respectively. No 
diagnosis was made in 2 (8%) pts. Dyspnea was the most common symptom 
@O%), while orthopnea (56%), cough (48%) and chest pain (40%) were also 
frequent complaints. Rales (56%), edema (52%) and a friction rub (40%) 
were common physical findings. At 1 year follow-up 3 (12%) pts had 
recurrent effusions and 1 pt required re-operation. This was not 
significantly different from the 32 pts without CT. 12 month mortality was 
also similar in both groups (36% and 44% respectively). CVD-induced PE 
was significantly (*pc.Ol) more common in those pts in CT when compared 
to the 32 pts without CT. Malignancy was equally divided between the 2 
groups while radiation-induced effusions rarely produced CT 
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Our findings, in contrast to previous reports, show that: 1) CT occurs in 
almost one-half of pts with large PE, 2) CVD is a frequent cause of CT 
while radiation therapy is an infrequent one, 3) thorough evaluation 
results in few idiopathic etiologies, and 4) subxiphoid pericardiotomy is an 
effective method of diagnosis and long-term treatment for pts in CI’. 
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Following initial study entry, a cohort of 
56 patients (pts) were determined by the 
Pathology Panel of the Myocarditis Treatment 
Trial to have definite myocarditis (H, n=30), 
No myocarditis (C, n-20) or indeterminate 
myocarditis (I, n=6). The prerandomization 
echocardiograms were then analyzed for indexed 
left ventricular size at snd diastoli and 
systole (LVEDDI and LVESDI), fractional 
shortening (FS), septal and posterior wall 
thickness (LVPW and IVS), heart rate (HR), left 
atria1 and right ventricular size (LA and RV). 
Only groups M and C were included in the 
analysis. LVPW, IVS, HR, fiA and RV were no 
different between groups. LVEDDI trended to be 
smaller in M compared to C (34.924.9 mm vs 
38.027.3, P-.102). LVESDI was smaller and FS 
was greater in W compared to C (28.6k9.3 mm vs 
32.5iS.l mm, e.0374; and 18.8k8.7 % vs 
13.6k7.7 0, plrt.031: respectively). Despite 
these significant differences, extensive 
overlap existed between groups M and C making 
echocardiographic differentiation impossible. 
These data do suggest that pts with biopsy 
proven myocarditis have less ventricular 
dilation and dysfunction compared to those with 
dilated cardiomyopathy. This finding could be 
consistent with myocardial restriction or 
myocardial disease of less severity or or 
shorter duration. 
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Pathology, 
Coxsackievirus B 3 (CVB 3) Induces severe 
infection. It was maximal -on 
inoculation, 
day 6 post 
coir.ciding with the peak of 
inflammatory cell Infiltration. 
Conclusions: 
1) CVB 3 infection leads to a considerable 
increase of MHC expression in the heart. 
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To test the hypothesis that atria1 natriure- 
tic factor (ANF) is a major contributor to the 
diuresis that follows relief of cardiac tampon- 
ade, we studied the changes in hemodynamics, 
atria1 volumes, plasma levels of ANF and cGMP, 
and urine flow rate in 10 patients (6M, 4F), 
underoing pericardiocentesis for tamponade. 
Relief of tamponade produced significant 
reductions in pulsus paradoxus, RA, pericardial 
and pulmonary wedge pressures and SVR, while 
increasing RA and LA volumes, CO and RA wall 
tension (p CO.05 or less). There was no signi- 
ficant change in mean BP, heart rate or PVR. 
Plasma ANF and cGMP (106 & 19 pg/ml and 19.5 & 
3.8 pmol/ml, mean f SEM, respectively) rose 
rapidly, peaking at 707 f: 128 and '2.8 f 4.8 
between 30 and 60 minutes after the t?p. 
Both ANF and cGMP remained elevated for 4 h 
after relief of tamponade and fell to 150% of 
pre-tap levels over the next 20 h. Urine flow 
rate averaged 0.8 f 0.2 ml/min pre-tap and 
increased to 3.2 f 0.5 (p ~0.002) during the 
first 8 h after tap and 2.2 a 0.4 (p co.01 vs 
pre-tap) for the ensuing 16 h. 
We conclude that relief of tamponade causes: 
1) atria1 stretch and increases in wall ten- 
sion, 2) the release of ANF at pharmacological- 
ly active levels and 2) the ANF contributes to 
the marked diuresis after pericardiocentesis. 
